Search for: "Anda Pharmaceuticals, Inc"
Results 61 - 80
of 610
Sorted by Relevance
|
Sort by Date
7 Aug 2018, 8:20 am
ANI Pharmaceuticals, Inc., 2018 WL 3677923, No. 17-4910 (D. [read post]
5 Dec 2008, 5:31 am
By Mark Chael -- On December 2nd, Mylan, Inc. and Mylan Pharmaceuticals, Inc. announced that they had settled their dispute with Novartis Pharmaceuticals Corp., Novartis Corp., and Novartis International AG over a generic version of Novartis' Femara ® tablets.According to the press release, Femara ® tablets, which are used in the treatment of breast cancer, had U.S. sales of about $470 million for the 12 months ending September 30, 2008.… [read post]
14 Jan 2020, 9:10 pm
The issue arose in ANDA litigation, where the District Court found claim 6 of U.S. [read post]
15 Feb 2017, 2:49 pm
Watson Pharmaceuticals, Inc., February 10, 2017, Hughes, T.). [read post]
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
23 Feb 2012, 8:46 pm
("IPC") and Intellipharmaceutics International Inc. [read post]
12 May 2014, 9:18 am
Anchen Pharmaceuticals, Inc., et al., C.A. [read post]
14 Dec 2006, 6:47 am
Cir. 2006, 05-1313) Impax had originally filed an ANDA with the FDA seeking approval to market generic riluzole (6-trifluoromethoxy-2-benzothiazolamine) tablets for the treatment of ALS and prompting a suit for a declaratory judgment that Impax did not infringe, induce [...] [read post]
6 Jun 2024, 10:07 am
Norwich Pharmaceuticals, Inc. 2023-1952 (Fed. [read post]
29 Jan 2013, 9:21 pm
Barr Laboratories, Inc., interesting. [read post]
3 Apr 2024, 1:07 pm
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
6 Sep 2010, 9:48 pm
Teva Pharmaceuticals USA, Inc. [read post]
15 Aug 2024, 8:18 pm
Hikma Pharmaceuticals USA Inc. [read post]
12 Apr 2015, 7:45 pm
Supernus Pharmaceuticals, Inc. v. [read post]
3 May 2016, 9:00 pm
Guest Post By: Paul Dietze and Mini Kapoor, Haynes and Boone, LLP[1] On March 18, 2016, the Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
30 Jun 2011, 2:13 pm
Patent No. 7,915,307...This action relates to an Abbreviated New Drug Application ("ANDA") filed by Mylan Pharmaceuticals, Inc. with the U.S. [read post]
11 Sep 2008, 4:55 am
Forest Laboratories, Inc. and Merck & Co. v. [read post]
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]
12 Dec 2010, 9:47 pm
-Florida; Watson Pharma, Inc.; Anda, Inc. [read post]
13 Sep 2017, 7:44 am
Mylan Pharmaceuticals, Inc., 1-17-cv-00379 (DED September 11, 2017, Order) (Stark, USDJ) [read post]
